The AGN-150998 data will be presented Nov 16-19 at AAO. Why are you so confident that safety is not part of the problem? AGN’s CC comment excerpted in #msg-87466434 emphasizes efficacy, but it mentions safety in a boilerplate way and is sufficiently vague that safety could conceivably be an issue, IMO.
The point of today’s presentation, of course, is to rally support among AGN shareholders for opposing the hostile offer from VRX.
VRX’s offer for AGN includes a CVR for the DARPin program that could be worth as much as $25/sh, but many investors are skeptical of the CVR (#msg-102591353).
AGN’s prior DARPin data are in #msg-87466434; the data disclosed today (see above) give a significantly more bullish picture.